Compare · EW vs UGRO
EW vs UGRO
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and urban-gro Inc. (UGRO): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while UGRO operates in Consumer Discretionary - the two are in different parts of the market.
- EW is the larger of the two at $48.58B, about 9828.6x UGRO ($4.9M).
- Over the past year, EW is up 9.8% and UGRO is down 71.8% - EW leads by 81.5 points.
- EW has been more active in the news (6 items in the past 4 weeks vs 5 for UGRO).
- EW has more recent analyst coverage (25 ratings vs 2 for UGRO).
- Company
- Edwards Lifesciences Corporation
- urban-gro Inc.
- Price
- $84.36-0.24%
- $3.13+10.39%
- Market cap
- $48.58B
- $4.9M
- 1M return
- -1.74%
- -43.05%
- 1Y return
- +9.75%
- -71.78%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 6
- 5
- Recent ratings
- 25
- 2
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
urban-gro Inc.
urban-gro, Inc. operates as an engineering design services company that integrates complex environmental equipment systems to create indoor cultivation facilities for the commercial horticulture market the United States, Canada, and Europe. The company offers engineering and design services, including cultivation space programming, integrated cultivation design, and full-facility mechanical, electrical, and plumbing engineering; training services ranging from equipment standard operating procedure libraries to staff training sessions; facility and equipment commissioning services; program overview and pricing; and related-party hardware and software platforms. It also offers an integrated suite of cultivation equipment systems and crop management products, which include environmental controls, fertigation and irrigation distribution, water treatment and wastewater reclamation systems, and purpose-built heating, ventilation, and air conditioning equipment systems; commercial horticulture lighting solutions; rolling and automated container benching systems; specialty fans; and microbial mitigation and odor reduction systems. The company was founded in 2014 and is based in Lafayette, Colorado.
Latest EW
- Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026
- CVP, EMEACLA Bruls Annette covered exercise/tax liability with 109 shares, decreasing direct ownership by 0.53% to 20,628 units (SEC Form 4) (for withholding tax)
- CVP, Chief Financial Officer Mistras Theodora was granted 99,920 shares (SEC Form 4)
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,762 worth of shares (619 units at $91.70) as part of a pre-agreed trading plan (SEC Form 4)
- CVP, TAVR Lippis Daniel J. covered exercise/tax liability with 377 shares, decreasing direct ownership by 0.93% to 40,034 units (SEC Form 4) to cover taxes
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,577 worth of shares (619 units at $91.40) as part of a pre-agreed trading plan (SEC Form 4)
- Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves
- CEO Zovighian Bernard J sold $45,982 worth of shares (523 units at $87.92) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 11-K filed by Edwards Lifesciences Corporation
- SEC Form 11-K filed by Edwards Lifesciences Corporation
Latest UGRO
- SEC Form 3 filed by new insider Herman Gary L
- SEC Form 3 filed by new insider Johri Rahul
- urban-gro Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form S-1 filed by urban-gro Inc.
- urban-gro Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- urban-gro Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form EFFECT filed by urban-gro Inc.
- urban-gro Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- urban-gro Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Amendment: SEC Form S-1/A filed by urban-gro Inc.